Developing a universal test for Crimean-Congo Hemorrhagic Fever virus.

Who could benefit from this research

What this research studies

This research focuses on creating a diagnostic tool called PANDAA that can detect the Crimean-Congo hemorrhagic fever virus (CCHFV) across various strains. The approach utilizes advanced probe-based qPCR technology to identify the virus even in its early stages, which can be challenging due to non-specific symptoms. By adapting to the genetic variations of the virus, this test aims to provide rapid and accurate results, improving diagnosis in resource-limited settings where CCHF is prevalent.

Why it matters

Where this research is happening

• Aldatu Biosciences, INC.
  Watertown, United States Active

Researchers

• Principal investigator: Macleod, Iain James — Aldatu Biosciences, INC.
• Study coordinator: Macleod, Iain James

Related research

Other NIH-funded projects on the same topics.

• Broad antiviral drugs that target coronaviruses and other viruses

  A research program aims to identify small molecules that can block multiple viruses, focusing first on coronaviruses, to help create drugs that can treat future outbreaks.

  NIH research Hackensack University Medical Center · Hackensack, United States · NIH-11617025

• Finding broadly protective antibodies against Crimean-Congo Hemorrhagic Fever

  Researchers will study blood from people who survived CCHF to find human antibodies that protect against multiple virus variants, with early tests in animal models to check their breadth.

  NIH research University of Maryland Baltimore · Baltimore, United States · NIH-11556149

• Antivirals for hemorrhagic fever viruses like LASV, SFTSV, and EBOV

  A multi-institutional effort to find and validate antiviral compounds that block key viral proteins from LASV, SFTSV, and EBOV to help people at risk from serious hemorrhagic fevers.

  NIH research Scripps Research Institute, the · La Jolla, United States · NIH-11542060

• A New Model for Valley Fever: Studying Coccidioides Infection with Volatile Clues in Wax Moths

  Researchers are testing a new, cheaper model using wax moths to study Valley Fever caused by Coccidioides, with the goal of understanding how the infection behaves and how it could be diagnosed or treated.

  NIH research Arizona State University-Tempe Campus · Scottsdale, United States · NIH-11439036

• Halogen-modified nucleoside analogs to fight yellow fever virus

  Aims to develop new oral medicines that could prevent or treat yellow fever by using specially modified building blocks that stop the virus from growing.

  NIH research Emory University · Atlanta, United States · NIH-11430119

• Understanding Guanarito virus and building countermeasures for Venezuelan hemorrhagic fever

  This project studies how Guanarito virus causes disease and aims to develop vaccines or treatments to protect people in areas where Venezuelan hemorrhagic fever occurs.

  NIH research University of Texas Med Br Galveston · Galveston, United States · NIH-11428214

About this research

1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.